<DOC>
	<DOCNO>NCT01401075</DOCNO>
	<brief_summary>Evaluation safety efficacy standardize mistletoe extract ( abnobaVISCUMÂ® Quercus , aVQ ) patient gastric cancer receive oral chemotherapy .</brief_summary>
	<brief_title>RCT With Adjuvant Mistletoe Treatment Gastric Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Viscum album peptide</mesh_term>
	<mesh_term>Doxifluridine</mesh_term>
	<mesh_term>Floxuridine</mesh_term>
	<criteria>postoperative UICC stage Ib/II gastric carcinoma indication oral chemotherapy doxifluridine ECOG performance status 0 1 normal liver kidney function inability answer QoL scale concomitant therapy steroid biological response modifier individual hypersensitivity mistletoe preparation pregnancy lactate participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Quality Life</keyword>
	<keyword>QoL</keyword>
	<keyword>EORTC QLQ-C30</keyword>
	<keyword>EORTC QLQ-STO22</keyword>
	<keyword>5-FU</keyword>
	<keyword>Viscum album</keyword>
</DOC>